Ocrelizumab Benefit Confirmed in Older Patients With MS Ocrelizumab Benefit Confirmed in Older Patients With MS

The relapse benefit of ocrelizumab in multiple sclerosis is confirmed for the first time in patients 60 and older starting therapy, say researchers in findings they hope will inform choices.Medscape Medical News
Source: Medscape Allergy Headlines - Category: Allergy & Immunology Tags: Neurology & Neurosurgery News Source Type: news